Format

Send to

Choose Destination
J Cancer. 2017 Sep 15;8(16):3212-3225. doi: 10.7150/jca.19794. eCollection 2017.

Long non-coding RNAs in Colorectal Cancer: Progression and Future Directions.

Yang Y1,2, Junjie P1,2, Sanjun C1,2, Ma Y1,2.

Author information

1
Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
2
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.

Abstract

Identification of the colorectal adenoma-carcinoma sequence with its corresponding genetic and epigenetic alterations has significantly increased our knowledge of the etiopathogenesis of colorectal cancer (CRC). However, the molecular mechanisms of colorectal carcinogenesis and metastasis haven't been clearly elucidated. Long non-coding ribonucleic acids (lncRNAs) are key participants of gene regulations rather than "noises". Accumulative studies have implicated that the aberrant expressions of lncRNAs are tightly corelated to CRC screening, diagnosis, prognosis and therapeutic outcomes. Our review focuses on recent findings on the involvement of lncRNAs in CRC oncogenesis and the lncRNA-based clinical implications in patients with CRC.

KEYWORDS:

Long noncoding RNA (lncRNA); biomarker; colorectal cancer (CRC); tumorigenesis

Conflict of interest statement

Competing Interests: The authors have declared that no competing interest exists.

Supplemental Content

Full text links

Icon for Ivyspring International Publisher Icon for PubMed Central
Loading ...
Support Center